Featured Research

from universities, journals, and other organizations

Scientists modify Botox for the treatment of pain

Date:
October 31, 2013
Source:
University of Sheffield
Summary:
Scientists have manufactured a new bio-therapeutic molecule that could be used to treat neurological disorders such as chronic pain and epilepsy.

A team of 22 scientists from 11 research institutes led by Professor Bazbek Davletov, now at the University of Sheffield, created and characterised a new molecule that was able to alleviate hypersensitivity to inflammatory pain.

The work is featured on the cover of the October 2013 issue of the scientific journal Bioconjugate Chemistry.

Professor Bazbek Davletov joined the Department of Biomedical Science in September last year from the Medical Research Council's Laboratory of Molecular Biology in Cambridge, where his team developed a new way of joining and rebuilding molecules.

By using elements of Clostridium botulinum and Clostridium tetani neurotoxins, commonly known as Botox and tetanus toxin respectively, the scientists were able to develop a molecule with new biomedical properties, without unwanted toxic effects.

While the Botox element is able to block neuronal communication -- and therefore pain signals -- for months, the tetanus component targets the central nervous system very effectively. The combination of the two elements is of great interest for neuroscience and can be applied to the treatment of several neurological disorders, particularly chronic pain conditions and epilepsy.

Botox and tetanus neurotoxins hold great promise for clinical applications, but their paralytic activity was a stumbling block until now. The team demonstrated that their newly engineered molecule is a potent non-paralysing neuronal blocker. Preclinical collaborative studies with Dr Enrico Ferrari at the University of Lincoln and Professor Stephen Hunt at University College London indicate usefulness of the new molecule for alleviation of inflammatory pain.

Professor Davletov added: "Currently painkillers relieve lingering pain only temporarily and often have unwanted side effects. A single injection of the new molecule at the site of pain could potentially relieve pain for many months in humans and this now needs to be tested. "We hope that the engineered molecule could improve the quality of life for those people who suffer from chronic pain. We are now negotiating transfer of the technology to a major pharmaceutical company."

Professor Davletov's team in the Department of Biomedical Science is now working not only on neuronal blockers tailored for various neurological conditions but also on developing new cancer drugs.


Story Source:

The above story is based on materials provided by University of Sheffield. Note: Materials may be edited for content and length.


Journal Reference:

  1. Enrico Ferrari, Chunjing Gu, Dhevahi Niranjan, Laura Restani, Christine Rasetti-Escargueil, Ilona Obara, Sandrine M. Geranton, Jason Arsenault, Tom A. Goetze, Callista B. Harper, Tam H. Nguyen, Elizabeth Maywood, John O’Brien, Giampietro Schiavo, Daniel W. Wheeler, Frederic A. Meunier, Michael Hastings, J. Michael Edwardson, Dorothea Sesardic, Matteo Caleo, Stephen P. Hunt, Bazbek Davletov. Synthetic Self-Assembling Clostridial Chimera for Modulation of Sensory Functions. Bioconjugate Chemistry, 2013; 24 (10): 1750 DOI: 10.1021/bc4003103

Cite This Page:

University of Sheffield. "Scientists modify Botox for the treatment of pain." ScienceDaily. ScienceDaily, 31 October 2013. <www.sciencedaily.com/releases/2013/10/131031103305.htm>.
University of Sheffield. (2013, October 31). Scientists modify Botox for the treatment of pain. ScienceDaily. Retrieved October 22, 2014 from www.sciencedaily.com/releases/2013/10/131031103305.htm
University of Sheffield. "Scientists modify Botox for the treatment of pain." ScienceDaily. www.sciencedaily.com/releases/2013/10/131031103305.htm (accessed October 22, 2014).

Share This



More Health & Medicine News

Wednesday, October 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

CDC Revamps Ebola Guidelines After Criticism

CDC Revamps Ebola Guidelines After Criticism

Newsy (Oct. 21, 2014) The Centers for Disease Control and Prevention have issued new protocols for healthcare workers interacting with Ebola patients. Video provided by Newsy
Powered by NewsLook.com
WHO: Ebola Vaccine Trials to Start a in January

WHO: Ebola Vaccine Trials to Start a in January

AP (Oct. 21, 2014) Tens of thousands of doses of experimental Ebola vaccines could be available for "real-world" testing in West Africa as soon as January as long as they are deemed safe in soon to start trials, the World Health Organization said Tuesday. (Oct. 21) Video provided by AP
Powered by NewsLook.com
First-Of-Its-Kind Treatment Gives Man Ability To Walk Again

First-Of-Its-Kind Treatment Gives Man Ability To Walk Again

Newsy (Oct. 21, 2014) A medical team has for the first time given a man the ability to walk again after transplanting cells from his brain onto his severed spinal cord. Video provided by Newsy
Powered by NewsLook.com
CDC Issues New Ebola Guidelines for Health Workers

CDC Issues New Ebola Guidelines for Health Workers

Reuters - US Online Video (Oct. 21, 2014) The U.S. Centers for Disease Control and Prevention has set up new guidelines for health workers taking care of patients infected with Ebola. Linda So reports. Video provided by Reuters
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins